NR3C1 (Ab-211) Antibody

What is the significance of NR3C1 Ser211 phosphorylation in glucocorticoid receptor function?

Phosphorylation of the glucocorticoid receptor (GR) at serine 211 is a critical post-translational modification that significantly enhances its transcriptional activity. This phosphorylation event promotes GR nuclear localization, increases protein stability, and enhances its interaction with transcriptional machinery. Specifically, Ser211 phosphorylation induces a functionally active folded conformation of the tau1c region within the N-terminal domain (NTD). This structural change facilitates interactions with essential coregulators including TATA-box binding protein (TBP), CREB binding protein (CBP), and nuclear receptor coactivator 1 (NCOA1/SRC-1) .

Research has demonstrated that phosphorylation-deficient S211A mutants fail to show significant structural rearrangements, while S211E phosphomimetic mutations only moderately increase helical content, suggesting the importance of the actual phosphorylation event rather than merely the negative charge .

Why study NR3C1/glucocorticoid receptor in different tissue contexts?

The glucocorticoid receptor, encoded by NR3C1, is widely distributed throughout the body and regulates genes controlling development, metabolism, and immune response . Its expression pattern and activity vary significantly across different tissues, resulting in context-specific functions:

Researchers should select appropriate cell models based on their specific research questions, as GR signaling mechanisms may differ substantially between tissue contexts .

How does the NR3C1 (Ab-211) antibody differ from other glucocorticoid receptor antibodies?

The NR3C1 (Ab-211) antibody specifically recognizes the region surrounding serine 211 of the glucocorticoid receptor, distinguishing it from antibodies targeting other domains or phosphorylation sites. This specificity makes it particularly valuable for studying GR activation status, as Ser211 phosphorylation is a marker of transcriptionally active receptor .

Key differences include:

• Target specificity: Unlike total GR antibodies, Ab-211 recognizes the specific amino acid sequence surrounding Ser211 (N-E-S-P-W)

• Phosphorylation status recognition: Differs from phospho-specific antibodies (like anti-GR phospho-S211) which exclusively detect the phosphorylated form

• Application versatility: Successfully validated for multiple applications including Western blot, immunohistochemistry, immunofluorescence, and ELISA across human, mouse, and rat samples

How does NR3C1 Ser211 phosphorylation status correlate with transcriptional outcomes in different experimental conditions?

The phosphorylation of NR3C1 at Ser211 serves as a molecular switch that significantly influences the receptor's transcriptional activity through several mechanisms:

Transcriptional complex assembly: Ser211 phosphorylation enhances recruitment of specific coactivators to the transcriptional machinery. Research has revealed that this phosphorylation increases interactions with TBP, CBP, and NCOA1 (SRC-1), facilitating assembly of productive transcriptional complexes .

Correlation with target gene expression patterns: Studies demonstrate that the degree of Ser211 phosphorylation directly correlates with expression levels of GR target genes. In leukemic cells, forskolin treatment increased both NR3C1 mRNA and protein levels while enhancing Ser211 phosphorylation, resulting in amplified expression of GR-responsive genes .

Temporal dynamics: The timing of Ser211 phosphorylation affects the transcriptional response. In dexamethasone treatment, initial GR protein levels decrease due to ubiquitination and degradation while maintaining high phospho-Ser211 levels, suggesting a complex regulatory mechanism that prioritizes transcriptional activity of the remaining receptor molecules .

Analysis of these phosphorylation-dependent transcriptional outcomes requires integrated approaches combining phospho-specific antibodies, chromatin immunoprecipitation, and transcriptomic profiling to establish causative relationships .

What are the molecular mechanisms by which NR3C1 enhancement affects autophagy in pancreatic β-cells?

Research has uncovered a complex molecular pathway connecting NR3C1 enhancement to hyperactive autophagy in pancreatic β-cells, which contributes to diabetes pathogenesis:

Epigenetic regulation pathway: NR3C1 enhancement upregulates the RNA demethylase FTO (fat mass and obesity associated) protein in β-cells. This upregulation causes diminished m6A (N6-methyladenosine) modifications on mRNAs of core autophagy-related genes (Atg12, Atg5, Atg16l2, Atg9a) .

Mechanistic effects on autophagy flux: Comprehensive experiments using autophagy markers reveal that:

• NR3C1 overexpression increases both autophagosomes (yellow dots) and autolysosomes (red-only dots) in cells expressing tandem mRFP-GFP-LC3

• Enhanced autophagy flux was confirmed by Bafilomycin A1 (Baf A1) treatment experiments

• Transmission electron microscopy demonstrated increased autophagic structures in NR3C1-overexpressed β-cells

Functional consequences: This hyperactive autophagy leads to:

• Impaired insulin secretion

• Decreased insulin content

• Increased β-cell apoptosis

• Compromised glucose homeostasis

Therapeutic implications: Importantly, inhibition of FTO (achieved by the specific inhibitor Dac51) prevented NR3C1-instigated excessive autophagy and effectively alleviated impaired insulin secretion and glucose intolerance in hyperglycemic mice with β-cell specific NR3C1 overexpression .

How do epigenetic modifications of NR3C1 correlate with stress exposure and adverse health outcomes?

Extensive research has established significant correlations between stress exposure, NR3C1 methylation, and various health outcomes:

Methylation patterns following stress exposure:

• NR3C1 methylation rates increase after exposure to stressful life events (SLEs) and traumatic youth experiences

• Both childhood and adolescent stress independently associate with higher NR3C1 methylation

• Timing of stress exposure matters: adolescent SLEs associate with NR3C1 methylation independent of childhood experiences

Physiological impacts and disease associations:
The altered NR3C1 methylation patterns following stress have been linked to:

Methodological considerations:
Researchers investigating these relationships should employ:

• Longitudinal study designs to capture temporal relationships

• Tissue-specific methylation analysis (blood vs. saliva samples show different patterns)

• Integration of genetic variants (e.g., 5HTTLPR polymorphisms) that may interact with methylation status

• Consideration of both genome-wide and gene-specific methylation approaches

What are the optimal protocols for using NR3C1 (Ab-211) antibody in different experimental applications?

Based on validated research protocols, here are optimized methodologies for different applications:

Western Blot (WB):

• Recommended dilution: 1:500-1:3000

• Sample preparation: Total protein from tissues or cell lysates (30μg/lane recommended)

• Detection system: Goat anti-rabbit IgG-HRP secondary antibody at 1:5000 dilution

• Expected band size: ~95-100 kDa (though calculated MW is 86 kDa)

• Validated positive controls: Placenta tissue lysates, HeLa cells, Jurkat cells, U87 cells, MCF-7 cells

Immunohistochemistry (IHC):

• Recommended dilution: 1:50-1:100

• Antigen retrieval: Heat-mediated in EDTA buffer (pH 8.0)

• Blocking: 10% goat serum

• Incubation: Overnight at 4°C

• Detection: Biotinylated goat anti-rabbit IgG secondary antibody with Streptavidin-Biotin-Complex (SABC) and DAB chromogen

Immunofluorescence (IF):

• Recommended dilution: 1:100-1:500

• Cell fixation: 70% ethanol (18h) or 4% paraformaldehyde (10 min)

• Blocking: 10% normal goat serum

• Secondary antibody: FITC-conjugated goat anti-rabbit IgG at 1:200 dilution

• Validated cell lines: A549 cells show strong nuclear staining

ELISA:

• Recommended dilution: 1:10000

• Coating: Overnight at 4°C

• Detection: HRP-conjugated secondary antibody with TMB substrate

• Quantification: Standard curve using recombinant NR3C1 protein

How should researchers optimize sample preparation to detect NR3C1 Ser211 in different tissue contexts?

Sample preparation is critical for reliable detection of NR3C1, particularly when studying the region around Ser211:

Cell/tissue lysis considerations:

• Use phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) to preserve phosphorylation status

• Include protease inhibitors to prevent protein degradation

• For nuclear proteins, perform subcellular fractionation to enrich for nuclear fraction where activated GR predominantly localizes

Tissue-specific optimization:

Experimental design for detecting dynamic changes:

• Include time-course experiments (15min, 30min, 1h, 2h, 6h) to capture temporal changes in phosphorylation

• Use paired samples (untreated/treated) from the same source to control for baseline variations

• Consider using phospho-enrichment techniques for low-abundance samples

• Include positive controls (e.g., forskolin-treated cells which increase both total NR3C1 and phospho-Ser211 levels)

What controls should be included when studying NR3C1 phosphorylation at Ser211?

Rigorous experimental design requires appropriate controls to ensure valid interpretation of NR3C1 phosphorylation data:

Essential positive controls:

• Forskolin-treated cells: Increases cAMP signaling, which enhances both NR3C1 expression and Ser211 phosphorylation

• Dexamethasone-treated cells (short-term): Induces Ser211 phosphorylation

• Recombinant phosphorylated peptide: Commercial phospho-peptide encompassing Ser211

Critical negative controls:

• Phosphatase-treated samples: Lambda phosphatase treatment removes phosphorylation

• Ser211 phosphorylation-deficient mutants (S211A): Cannot be phosphorylated at this site

• siRNA/shRNA-mediated NR3C1 knockdown cells: For antibody specificity validation

Parallel detection approaches:

• Compare total NR3C1 antibody with phospho-specific antibody to determine phosphorylation ratio

• Use phosphomimetic mutants (S211E) as reference points

• Include blocking peptide controls to confirm antibody specificity

• Employ mass spectrometry validation for absolute confirmation of phosphorylation status

Biological context controls:

• Include known GR target genes (e.g., GILZ, FKBP5) as functional readouts of GR activation

• Assess nuclear translocation status alongside phosphorylation

• Compare effects of different GR ligands (dexamethasone, cortisol, RU486) on phosphorylation patterns

How can researchers troubleshoot inconsistent results when using NR3C1 (Ab-211) antibody?

When encountering variability in NR3C1 (Ab-211) antibody results, consider these systematic troubleshooting approaches:

Western Blot Issues and Solutions:

Immunostaining Variability:

• Fixation effects: Overfixation can mask epitopes; compare 4% PFA (10 min) with methanol fixation

• Antigen retrieval: Heat-mediated retrieval in EDTA buffer (pH 8.0) outperforms citrate buffer for this epitope

• Background reduction: Use 0.3% H₂O₂ pre-treatment for IHC; include 0.1% Triton X-100 for permeabilization in IF

• Signal amplification: Consider tyramide signal amplification for low abundance detection

Batch-to-batch variation management:

• Maintain consistent positive controls across experiments

• Standardize lysate preparation protocols

• Test each new antibody lot against a reference sample

• Document detailed experimental conditions for reproducibility

What factors influence the interpretation of NR3C1 phosphorylation data in stress-related research?

Interpreting NR3C1 phosphorylation data in stress research requires careful consideration of multiple biological and methodological factors:

Timing considerations:

• Glucocorticoid circadian rhythms significantly affect baseline NR3C1 phosphorylation

• Acute vs. chronic stress models produce different phosphorylation patterns

• Time course experiments are essential to capture dynamic phosphorylation changes

Tissue specificity:

• Brain regions show heterogeneous NR3C1 expression and phosphorylation responses

• Peripheral tissues (immune cells, liver, adipose) display distinct temporal dynamics

• Cell-type specific responses within tissues may be masked in whole-tissue analysis

Stress type and duration:

• Physical vs. psychological stressors activate different signaling pathways

• Early life stress vs. adult stress produces different epigenetic patterns affecting NR3C1 expression

• Recovery periods between stressors significantly impact phosphorylation status

Methodological considerations:

• Sample collection timing relative to stressor application

• Consideration of baseline individual variations (genetic background)

• Use of both phospho-specific and total NR3C1 antibodies for proper ratio calculation

• Integration with functional measures (e.g., corticosterone levels, behavioral outcomes)

How should discrepancies between NR3C1 mRNA levels and protein expression be reconciled in experimental data?

Researchers frequently encounter discrepancies between NR3C1 mRNA and protein levels. Understanding the mechanisms behind these disparities is crucial for accurate data interpretation:

Mechanisms underlying mRNA-protein discrepancies:

• Post-transcriptional regulation:

  • m6A methylation affects mRNA stability and translation efficiency

  • MeRIP-seq analysis has revealed that NR3C1 enhancement alters m6A modification patterns of multiple genes

  • RNA-binding proteins can selectively enhance or suppress translation

• Post-translational regulation:

  • Ligand-induced receptor degradation: Dexamethasone treatment reduces NR3C1 protein despite increasing mRNA due to ubiquitination and degradation

  • Phosphorylation affects protein stability: Ser211 phosphorylation enhances receptor stability

  • Proteasomal degradation rates vary between experimental conditions

• Methodological factors:

  • Sample timing: Protein changes typically lag behind mRNA changes

  • Detection sensitivity differences between RT-qPCR and Western blot methods

  • Cell-specific translation efficiency variations

Best practices for reconciliation:

• Perform time-course experiments capturing both mRNA and protein at multiple timepoints

• Include protein synthesis inhibitors (cycloheximide) and proteasome inhibitors (MG132) to determine turnover rates

• Use absolute quantification methods for both mRNA (digital PCR) and protein (quantitative proteomics)

• Employ polysome profiling to assess translation efficiency of NR3C1 mRNA

• Consider reporter constructs to directly monitor post-transcriptional regulation

How is NR3C1 (Ab-211) antibody being used to study stress-induced epigenetic modifications?

NR3C1 (Ab-211) antibody has become instrumental in studying the relationship between stress exposure and epigenetic modifications:

Chromatin immunoprecipitation applications:
Researchers are combining NR3C1 (Ab-211) antibody with ChIP-seq approaches to:

• Map genome-wide binding patterns of GR following stress exposure

• Identify stress-responsive enhancers and promoters

• Correlate Ser211 phosphorylation status with chromatin occupancy

Integration with methylation studies:
The antibody has enabled researchers to establish connections between:

• Early life adversity and NR3C1 methylation patterns

• Stressful life events in adolescence and altered GR function

• Trauma exposure and long-term changes in stress responsivity

Novel research applications:

• Single-cell approaches: Combining phospho-flow cytometry with NR3C1 (Ab-211) antibody to assess cell-specific responses to stress

• Longitudinal studies: Tracking NR3C1 phosphorylation changes over time in response to chronic stress

• Intervention research: Evaluating how therapeutic interventions (pharmacological or behavioral) normalize stress-induced alterations in GR function

These applications have revealed that not only traumatic experiences but also common stressful life events can induce significant epigenetic changes in NR3C1, with particular sensitivity during the adolescent period .

What role does NR3C1 phosphorylation at Ser211 play in glucocorticoid resistance in cancer and inflammatory conditions?

Phosphorylation of NR3C1 at Ser211 has emerged as a critical factor in glucocorticoid therapy resistance:

Cancer research insights:

• Leukemia cells with GNAS deficiency show reduced NR3C1 expression and Ser211 phosphorylation, correlating with dexamethasone resistance

• GNAS knockdown in human T-ALL cells shifted the dexamethasone dose response by approximately 200-fold (from 0.1 to 26 nM)

• Forskolin-induced increases in cAMP signaling restored both NR3C1 expression and Ser211 phosphorylation, resensitizing cells to glucocorticoids

Inflammatory condition mechanisms:

• Reduced Ser211 phosphorylation correlates with decreased anti-inflammatory effects of glucocorticoids

• Inflammatory cytokines can interfere with GR phosphorylation pathways

• Restoration of proper phosphorylation patterns may overcome steroid resistance

Mechanistic pathway analysis:

• cAMP signaling → increased NR3C1 expression → enhanced Ser211 phosphorylation → improved glucocorticoid sensitivity

• GNAS deficiency → reduced cAMP → decreased NR3C1 and phospho-Ser211 → glucocorticoid resistance

This research suggests potential therapeutic approaches:

• Adenylate cyclase activators (like forskolin) as adjuvants to glucocorticoid therapy

• Targeted enhancement of pathways promoting Ser211 phosphorylation

• Development of biomarkers based on phosphorylation status to predict therapy response

How is NR3C1 (Ab-211) antibody contributing to research on metabolic disorders and diabetes?

The NR3C1 (Ab-211) antibody has become a valuable tool in metabolic research, particularly regarding the role of glucocorticoid signaling in diabetes pathogenesis:

Pancreatic β-cell dysfunction research:
Recent studies utilizing this antibody have revealed:

• NR3C1 activation promotes deleterious hyperactive autophagy in β-cells exposed to glucolipotoxicity

• The NR3C1-FTO-m6A modifications-Atg genes pathway represents a novel mechanism underlying β-cell failure

• Inhibition of this pathway effectively alleviated impaired insulin secretion and glucose intolerance in diabetic models

Mechanistic insights gained:

• RNA sequencing combined with NR3C1 protein analysis identified autophagy as the most enriched pathway affected by glucocorticoid receptor activation

• Methylated RNA immunoprecipitation sequencing (MeRIP-seq) revealed that NR3C1 enhancement-induced alterations in m6A modification were significantly enriched in autophagy-related genes

• Visualization techniques using the antibody confirmed increased autophagic flux in NR3C1-overexpressing β-cells

Therapeutic implications:

• FTO inhibition (via Dac51) prevented NR3C1-instigated excessive autophagy

• NR3C1 knockdown experiments reversed impaired β-cell secretion in human islets

• Autophagy inhibition (via 3-MA, Baf A1 or Atg5/Atg7 knockdown) rescued insulin secretion and content